While the advisory committees’ recommendations are not binding, the FDA typically follows those endorsements when it comes to final approval of a new drug. A recent study conducted by the Milbank Quarterly found that the FDA followed the guidelines of the scientific advisory committees 78%of the time. To come to that conclusion, researchers examined public documents from FDA advisory committee meetings and medical product databases for all FDA advisory committee meetings from 2008 through 2015.
https://www.biospace.com/article/a-look-at-the-relationship-between-fda-advisory-committees-the-agency-and-drug-approvals/
Mesoblast now expects to release Ryoncil positive ruling on Monday, page-27
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.020(1.95%) |
Mkt cap ! $1.193B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.07 | $1.02 | $7.487M | 7.196M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 39700 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 86509 | 6 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.05 |
Change
0.020 ( 1.89 %) |
||||
| Open | High | Low | Volume | ||
| $1.02 | $1.07 | $1.02 | 1379563 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| MSB (ASX) Chart |